Research Topic · Peer-Reviewed

Assessment of Malignant Diseases

Assessment of malignant diseases is the systematic process of detecting, characterizing, and staging cancer to establish a diagnosis and guide treatment. It integrates clinical evaluation with laboratory, pathological, and imaging methods to determine whether a lesion is malignant, define its type and biological fea…

Curated from this journal's research 📚 10 peer-reviewed articles cited Cited 131× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed June 2026

Overview

Assessment of malignant diseases is the systematic process of detecting, characterizing, and staging cancer to establish a diagnosis and guide treatment. It integrates clinical evaluation with laboratory, pathological, and imaging methods to determine whether a lesion is malignant, define its type and biological features, and gauge its extent. Tissue and cellular diagnosis is central, achieved through cytology, including fine needle aspiration that classifies samples along a spectrum from benign to suspicious to malignant, and through histopathology, which identifies tumor type, grade, and architecture. Biochemical and biomarker analyses complement morphology: enzyme levels such as lactate dehydrogenase can reflect disease burden, and tissue or fluid concentrations of specific markers and trace elements have been explored as adjuncts in screening and characterization of malignancies, including hematologic cancers and prostate disease. Imaging contributes to detection, localization, and the delineation of target volumes for treatment planning, while staging consolidates these findings to describe tumor size, nodal involvement, and metastatic spread. In hematology and oncology, assessment spans leukemias, lymphomas, and solid tumors and often requires an interdisciplinary approach combining blood and marrow analysis with imaging. Accurate assessment underpins decisions about curative or palliative therapy, enables monitoring of response and recurrence, and supports prognostication. By converging multiple diagnostic modalities, it provides the evidence base for individualized cancer management.

Research published in this journal

10 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 10 articles above have been cited 131 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Assessment of Malignant Diseases, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.